A3856112
4,5-Dichlorothiophene-2-carboxylic acid , 98% , 31166-29-7
CAS NO.:31166-29-7
Empirical Formula: C5H2Cl2O2S
Molecular Weight: 197.04
MDL number: MFCD07366674
EINECS: 1312995-182-4
| Pack Size | Price | Stock | Quantity |
| 50MG | RMB37.60 | In Stock |
|
| 250MG | RMB104.00 | In Stock |
|
| 1g | RMB242.40 | In Stock |
|
| 5g | RMB815.20 | In Stock |
|
| 10g | RMB1620.00 | In Stock |
|
| 25g | RMB3439.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 196-197 °C |
| Boiling point: | 315.3±37.0 °C(Predicted) |
| Density | 1.708±0.06 g/cm3(Predicted) |
| storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C |
| solubility | DMSO, Methanol (Slightly) |
| form | Solid |
| pka | 3.31±0.10(Predicted) |
| color | Pale Beige to Dark Brown |
| InChI | InChI=1S/C5H2Cl2O2S/c6-2-1-3(5(8)9)10-4(2)7/h1H,(H,8,9) |
| InChIKey | JDBAYLWBVQVMTD-UHFFFAOYSA-N |
| SMILES | C1(C(O)=O)SC(Cl)=C(Cl)C=1 |
Description and Uses
4,5-Dichlorothiophene-2-carboxylic Acid is used in the preparation of compounds that have therapeutic BACE1 and BACE2 inhibitors which are used for the treatment of Alzheimer’s disease, type 2 diabetes and other metabolic disorders.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H317-H319 |
| Precautionary statements | P280-P305+P351+P338 |
| Risk Statements | 36/37/38-20/22 |
| Safety Statements | 20-26-35 |
| HS Code | 29349990 |







